Albumedix announces evaluation agreement with a top pharma collaborator

Novartis and Albumedix Ltd. (‘Albumedix’) have entered into an agreement to evaluate the development of several first-in-class therapeutics using Albumedix’s Veltis®technology platform and associated technologies.

Novartis will evaluate molecules in combination with Albumedix´s engineered albumin variants for enhanced delivery. Beyond the modulation of pharmacokinetic profiles, the potential for novel routes of administration and mechanisms of action will be assessed. Novartis will evaluate Albumedix’s Veltis technology across multiple therapeutic areas and against multiple targets.

This collaboration is an excellent example of how our Veltis technology platform holds great potential for optimizing the therapeutic performance of pharmaceuticals across a broad range of targets and indications. We look forward to a strong collaboration with the various research teams at Novartis for the advancement of albumin-enabled therapeutics.”

Dr. Phil Morton, Chief Technology Officer, Albumedix

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Albumedix Ltd.. (2019, August 20). Albumedix announces evaluation agreement with a top pharma collaborator. News-Medical. Retrieved on October 05, 2024 from https://www.news-medical.net/news/20190820/Albumedix-announces-evaluation-agreement-with-a-top-pharma-collaborator.aspx.

  • MLA

    Albumedix Ltd.. "Albumedix announces evaluation agreement with a top pharma collaborator". News-Medical. 05 October 2024. <https://www.news-medical.net/news/20190820/Albumedix-announces-evaluation-agreement-with-a-top-pharma-collaborator.aspx>.

  • Chicago

    Albumedix Ltd.. "Albumedix announces evaluation agreement with a top pharma collaborator". News-Medical. https://www.news-medical.net/news/20190820/Albumedix-announces-evaluation-agreement-with-a-top-pharma-collaborator.aspx. (accessed October 05, 2024).

  • Harvard

    Albumedix Ltd.. 2019. Albumedix announces evaluation agreement with a top pharma collaborator. News-Medical, viewed 05 October 2024, https://www.news-medical.net/news/20190820/Albumedix-announces-evaluation-agreement-with-a-top-pharma-collaborator.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Albumedix ground-breaking ceremony